Jafri Hasan 4
4 · Aridis Pharmaceuticals, Inc. · Filed Sep 8, 2021
Insider Transaction Report
Form 4
Jafri Hasan
Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-09-07$3.97/sh+100$397→ 5,100 total - Purchase
Common Stock
2021-09-03$4.15/sh+3,009$12,487→ 3,009 total - Purchase
Common Stock
2021-09-07$4.15/sh+1,991$8,263→ 5,000 total